USPTO 2015–2025 USPTO PatentsView US Corporation

EDWARDS LIFESCIENCES CORPORATION

USPTO PatentsView assignee record — 1,265 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

1,265
Total patents granted
51
CPC technology areas
18.6
Avg claims per patent
+115%
5-year filing velocity

Portfolio overview

EDWARDS LIFESCIENCES CORPORATION has been granted 1,265 US utility patents between 2015 and 2025, placing EDWARDS LIFESCIENCES CORPORATION at rank #340 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, EDWARDS LIFESCIENCES CORPORATION is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 67.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 864 grants, compared with 401 in the 2015–2019 window — a +115% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. EDWARDS LIFESCIENCES CORPORATION's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark EDWARDS LIFESCIENCES CORPORATION against peers pursuing similar technology classes.

How does EDWARDS compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows EDWARDS holds 1,265 patents — placing it at rank #340 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

050100150200 20152016201720182019202020212022202320242025 132
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
EDWARDS LIFESCIENCES CORPORATION patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 49 3.9%
2016 66 5.2%
2017 61 4.8%
2018 91 7.2%
2019 134 10.6%
2020 153 12.1%
2021 157 12.4%
2022 112 8.9%
2023 138 10.9%
2024 172 13.6%
2025 132 10.4%

Which technologies does EDWARDS LIFESCIENCES CORPORATION patent most?

Top 15 of 51 technology areas

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#340

Across all tracked assignees

Innovation Score

67.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does EDWARDS LIFESCIENCES CORPORATION hold?
EDWARDS LIFESCIENCES CORPORATION holds 1,265 US granted patents filed between 2015 and 2025, spanning 51 technology areas.
What is EDWARDS LIFESCIENCES CORPORATION's Innovation Score?
EDWARDS LIFESCIENCES CORPORATION has an Innovation Score of 67.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does EDWARDS LIFESCIENCES CORPORATION focus on?
EDWARDS LIFESCIENCES CORPORATION's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 1,101 patents. The company has filed patents in 51 CPC subclasses total.
Is EDWARDS LIFESCIENCES CORPORATION's patent filing rate increasing or decreasing?
EDWARDS LIFESCIENCES CORPORATION's recent filing velocity is +115% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for EDWARDS LIFESCIENCES CORPORATION's patents?
EDWARDS LIFESCIENCES CORPORATION's patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the EDWARDS LIFESCIENCES CORPORATION patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope